Envestnet Portfolio Solutions Inc. Has $2.72 Million Stake in STERIS plc (NYSE:STE)

Envestnet Portfolio Solutions Inc. decreased its holdings in STERIS plc (NYSE:STE - Free Report) by 33.5% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 13,213 shares of the medical equipment provider's stock after selling 6,651 shares during the quarter. Envestnet Portfolio Solutions Inc.'s holdings in STERIS were worth $2,716,000 as of its most recent SEC filing.

Other institutional investors have also recently bought and sold shares of the company. Avalon Trust Co bought a new position in STERIS in the 4th quarter valued at $30,000. Human Investing LLC acquired a new stake in shares of STERIS in the 4th quarter valued at $31,000. Anfield Capital Management LLC increased its stake in shares of STERIS by 100.0% in the 4th quarter. Anfield Capital Management LLC now owns 182 shares of the medical equipment provider's stock valued at $37,000 after buying an additional 91 shares during the period. Central Pacific Bank Trust Division increased its stake in shares of STERIS by 65.5% in the 4th quarter. Central Pacific Bank Trust Division now owns 192 shares of the medical equipment provider's stock valued at $39,000 after buying an additional 76 shares during the period. Finally, Manchester Capital Management LLC increased its stake in shares of STERIS by 182.7% in the 4th quarter. Manchester Capital Management LLC now owns 212 shares of the medical equipment provider's stock valued at $44,000 after buying an additional 137 shares during the period. Institutional investors own 94.69% of the company's stock.

STERIS Trading Down 2.3 %

Shares of STERIS stock traded down $5.13 during trading on Friday, reaching $220.34. 1,348,122 shares of the company were exchanged, compared to its average volume of 504,416. The company has a quick ratio of 1.40, a current ratio of 2.13 and a debt-to-equity ratio of 0.32. STERIS plc has a twelve month low of $197.82 and a twelve month high of $248.24. The business has a 50-day moving average price of $221.02 and a 200-day moving average price of $221.97. The firm has a market capitalization of $21.65 billion, a price-to-earnings ratio of 46.78 and a beta of 0.92.

Remove Ads

STERIS (NYSE:STE - Get Free Report) last announced its quarterly earnings data on Wednesday, February 5th. The medical equipment provider reported $2.32 EPS for the quarter, missing analysts' consensus estimates of $2.33 by ($0.01). STERIS had a return on equity of 13.91% and a net margin of 8.66%. Sell-side analysts anticipate that STERIS plc will post 9.08 EPS for the current fiscal year.

STERIS Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, March 21st. Shareholders of record on Thursday, February 20th were paid a $0.57 dividend. The ex-dividend date of this dividend was Thursday, February 20th. This represents a $2.28 dividend on an annualized basis and a yield of 1.03%. STERIS's payout ratio is 48.41%.

Wall Street Analysts Forecast Growth

STE has been the subject of several research reports. Piper Sandler lifted their target price on STERIS from $260.00 to $265.00 and gave the company an "overweight" rating in a research note on Monday, February 3rd. Stephens reissued an "overweight" rating and issued a $240.00 target price on shares of STERIS in a research note on Thursday, February 6th. Finally, JMP Securities reissued a "market outperform" rating and issued a $265.00 target price on shares of STERIS in a research note on Thursday, February 6th. One analyst has rated the stock with a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average target price of $258.75.

About STERIS

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.